<DOC>
	<DOCNO>NCT00518375</DOCNO>
	<brief_summary>This study evaluate renal graft function ( base calcuated creatinine clearance ) 12 month transplantation patient receive either regimen reduce dose standard dose cyclosporine combination sirolimus corticosteroid . The incidence acute graft rejection 6 12 month follow transplantation patient graft survival 12 month evaluate also .</brief_summary>
	<brief_title>Study Comparing Graft Function Renal Allograft Recepients Receiving Reduced Standard Dose CsA With Sirolimus</brief_title>
	<detailed_description>This study evaluate renal graft function ( base calcuated creatinine clearance ) 12 month kidney transplantation patient receive either regimen reduce dose standard dose cyclosporine ( CsA ) combination sirolimus corticosteroid . The incidence acute graft rejection 6 12 month follow transplantation patient graft survival 12 month transplantation evaluate also .</detailed_description>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Adults 18 year age Endstage renal disease , patient receive primary secondary renal allograft cadaveric , livingunrelated livingrelated mismatched donor Patients secondary transplant must maintain primary graft least 6 month Planned antibody induction therapy Multiple organ transplant Patients high risk acute rejection</criteria>
	<gender>All</gender>
	<minimum_age>18 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
</DOC>